home / stock / pavmz / pavmz news

PAVMZ News and Press, PAVmed Inc. Series Z Warrant From 04/24/19

Stock Information
Company Name: PAVmed Inc. Series Z Warrant
Stock Symbol: PAVMZ
Market: NASDAQ
Website: pavmed.com
Menu
PAVMZ PAVMZ Quote PAVMZ Short PAVMZ News PAVMZ Articles PAVMZ Message Board
Get PAVMZ Alerts

News, Short Squeeze, Breakout and More Instantly...
PAVMZ - PAVmed Reports Excellent DisappEAR(TM) Animal Study Results

Resorbable pediatric ear tube expected to benefit up to one million U.S. children per year NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device compa...
PAVMZ - PAVmed Announces Registered Direct Offering of its Common Stock

NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has entered into agreements for the sale of 1,655,000 shares of common s...

PAVMZ - PAVmed Reports Fourth Quarter 2018 Financial Results and Provides Business Update

Conference call to be held on April 4, 2019 at 4:30 p.m. Eastern time NEW YORK, April 04, 2019 (GLOBE NEWSWIRE) --   PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today repo...

PAVMZ - PAVmed to Hold Business Update Conference Call on April 4, 2019

NEW YORK, March 21, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the Company will report fourth quarter 2018 financial results on or be...
PAVMZ - PAVmed Announces NextFlo(TM) Breakthrough

Groundbreaking disposable gravity-driven intravenous (IV) infusion set achieves flow accuracy comparable to expensive electronic infusion pumps, independent of IV bag height. NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or...

PAVMZ - PAVmed Announces PortIO(TM) Breakthrough

Groundbreaking i mplantable intraosseous vascular access device achieves unprecedented maintenance-free implant duration of over 60 days in pre-clinical testing NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVm...

PAVMZ - PAVmed Subsidiary Lucid Diagnostics Launches World-Class Medical Advisory Board and Appoints Chief Medical Officer

NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product medical device company, today announced that its subsidiary, Lucid Diagnostics Inc. (“Lucid”), has la...
PAVMZ - PAVmed Provides Business Update

NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today provided an update on its business. “I am pleased to report that PAVmedȁ...

Previous 10 Next 10